Cullen/Frost Bankers, Inc.
NYSECullen/Frost Bankers has emerged from its July 30 Q2 earnings release with a wave of upward analyst revisions, yet the stock at $168.26 trades fractionally below the newly raised consensus target — a narrower gap than existed heading into the print, and the key tension worth watching now. The Street response to the Q2 results has been unusually uniform in direction. Five firms…
Snapshot as of 15 Aug 2026
Cullen/Frost Bankers has emerged from its July 30 Q2 earnings release with a wave of upward analyst revisions, yet the stock at $168.26 trades fractionally below the newly raised consensus target — a narrower gap than…
CFR reports second-quarter results on July 30 with the stock already trading above the average analyst price target — a setup that puts the burden of proof squarely on the earnings release. The most striking feature of…
CFR heads into its July 30 earnings date with a notable split: analysts are warming up while short sellers are heading for the exit. The most striking move of the past two weeks is the wave of analyst target upgrades.…
Cullen/Frost Bankers heads into Q2 earnings season with a striking tension at its core: the stock is up 14% in a month, yet short sellers are piling in at the fastest pace in years while analysts are cutting their…
Cullen/Frost Bankers enters its Q1 2026 earnings call on April 30 with shorts unwinding sharply, options leaning bullish, and the Street split between cautious neutrals and a persistent Underweight from Morgan…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CFR — free to start on ORTEX.
Sign up for free →Open CFR on ORTEX